Our data show a novel signalling mechanism, initiated by activation of the EGF receptor in GBM cells, which promotes the p38-MAPK-dependent expression of ODZ1, a previously characterized invasion factor for tumor cells. This evidence concerns the gene MAPK14 and glioblastoma.